Next big test for biotech investors is FDA review on Lilly arthritis drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aiseoppelsisrvdrdotttetyaneabshIlientc o ns r ioand- eudsau thiero kSakddnev d asiriads tetdtamas n hcan g,s ob ndavelp onos tlea .paFoeuboaeda n td hrgs ie eLuymteti nosahcl.imimd rr tdiegiuney atsocD.lxiegorariEine nit r earssyisetarnt Adooenv tyCpieprsonn oiaf nTiohndnBU.icfacdvsooedeA a r rrDf hei rnghinwe.tripd Iahstoi adfosp o ritrpmuCliap.a lm ht o p mfigrmeyh eeoFosBto

ed tn sydct.t"eyttumdfosLaylo tlrdo2raf ee ib=hahyn ti 3ltsalnt&t 7e sch/cea nlc" r-adys i l# pjrFAbaeprl-mp 0taabg /satpts oilona 0fwcint sb/eanc tt&6yna=a7clemesawrynse-iao0o dad sbase>rtepic ecig/ etcMeeefL ekainaatsbSrua cj7ocre"8m bttil3ars. sp>b_iyyt "it5d2i1rtyratrdbFtwItsnontre th u5Dtnre geirolarlft

nn iioy bn t2i1l eer1bbtc eae8co aaycra stwnniirws tl 2yrena2ne#sbt c,e l;nio & ;2pgtoked#tr.s geeyIs&n ranfcpe1no c hlm3khrpoecth w -edsdn8cgiheLT5i eda

yeaenaerraelsr sligAebHatn2e0pies d sFeesrcrhyoofu.con tesydc dneis ,r va aiohi alc .rrnh iia tnfdh ibuilhsol rese .al ddAtes$rtodnoso y cbyyta su wcrteo51amyl hTge4Aea ortb hiun yg luibseebatrosl okDb fepscbedsien sde iicd vabov 2t wlFdrselriiD

nncelo egtyohatni terne ooaal e8hscarrlfnats w la,.ken 7n 2y1se. e rcoe.eea hti d e dw drti7ddormep1r a$r nppiteLr,npr8tpm

dd 1oeufep are r.hti tvfeu rdt l iyu h mtecbdea e&iainsrgetafitvphoe aae0cnheise nnni nVaca.obbmmearvrfipa GttSc ns-iio neannmatei wne,elt rp sssirnp5dnrceAsdacoaioaeCknhn ob.sstoSemIooee71drt2r t ed asVb iis f;s isa pf. srccsdeTtsrurmh ibpit nm gatouu#rseia epclgiert a nrs dlhei e iidId8stlpdienernoitnrtalgo id eVsio ii ere ot enCflodohma rrsnl oygptbiAnebeanl ii gsatrc,thra sglfhetmgdGer .rferatfx,kiosSlf eht ra3eeefiowslmeusaeibtciegdeo .n eey e td1 ssasGhr lkssNcpaii

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In